Complete financial analysis of GreenLight Biosciences Holdings (GRNAW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GreenLight Biosciences Holdings, a leading company in the Biotechnology industry within the Healthcare sector.
- Banaras Beads Limited (BANARBEADS.NS) Income Statement Analysis – Financial Results
- O-TA Precision Industry Co., Ltd. (8924.TWO) Income Statement Analysis – Financial Results
- Chico’s FAS, Inc. (CHS) Income Statement Analysis – Financial Results
- Richardson Electronics, Ltd. (RELL) Income Statement Analysis – Financial Results
- The Trade Desk, Inc. (0LF5.L) Income Statement Analysis – Financial Results
GreenLight Biosciences Holdings (GRNAW)
About GreenLight Biosciences Holdings
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 6.38M | 0.00 | 962.00K | 3.00M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 6.38M | 0.00 | 962.00K | 3.00M |
| Gross Profit Ratio | 100.00% | 0.00% | 100.00% | 100.00% |
| Research & Development | 133.81M | 89.83M | 42.87M | 23.49M |
| General & Administrative | 35.93M | 20.32M | 11.17M | 8.71M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 35.93M | 20.32M | 11.17M | 8.71M |
| Other Expenses | -396.00K | -1.60M | -785.00K | 0.00 |
| Operating Expenses | 169.34M | 108.56M | 53.25M | 32.20M |
| Cost & Expenses | 169.34M | 108.56M | 53.25M | 32.20M |
| Interest Income | 895.00K | 37.00K | 83.00K | 865.00K |
| Interest Expense | 4.12M | 2.42M | 1.03M | 317.00K |
| Depreciation & Amortization | 9.93M | 5.81M | 1.84M | 1.55M |
| EBITDA | -153.99M | -102.75M | -50.45M | -27.65M |
| EBITDA Ratio | -2,412.11% | 0.00% | -5,243.97% | -921.33% |
| Operating Income | -163.92M | -108.56M | -52.28M | -29.20M |
| Operating Income Ratio | -2,567.65% | 0.00% | -5,434.93% | -973.08% |
| Total Other Income/Expenses | -2.04M | -3.75M | -967.00K | 553.00K |
| Income Before Tax | -165.96M | -112.31M | -53.25M | -28.65M |
| Income Before Tax Ratio | -2,599.67% | 0.00% | -5,535.45% | -954.65% |
| Income Tax Expense | 1.09M | 2.42M | 1.03M | 317.00K |
| Net Income | -167.06M | -114.73M | -54.28M | -28.97M |
| Net Income Ratio | -2,616.78% | 0.00% | -5,642.31% | -965.21% |
| EPS | -1.27 | -0.93 | -0.56 | -0.30 |
| EPS Diluted | -1.27 | -0.93 | -0.56 | -0.30 |
| Weighted Avg Shares Out | 131.98M | 122.82M | 96.35M | 96.35M |
| Weighted Avg Shares Out (Dil) | 131.98M | 122.82M | 96.35M | 96.35M |
Source: https://incomestatements.info
Category: Stock Reports